Marjorie Taylor Greene slams FDA green lighting of mNEXSPIKE COVID-19 vaccine: 'Not MAHA at all!!!'
Rep. Marjorie Taylor Greene, R-Ga., slammed the U.S. Food and Drug Administration's move to give the green light to Moderna's mNEXSPIKE Covid-19 vaccine.
"Not MAHA at all!!!," the congresswoman wrote in a post on X, using the acronym for the phrase "Make America Healthy Again," calling the move "Unreal."
"MNEXSPIKE is approved for use in individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years of age and older, or 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19," an FDA letter to Moderna notes.
Greene Calls For Yanking Fda Approval Of Covid-19 Vaccines: 'Causing Permanent Harm And Deaths'
According to a Moderna press release, CEO Stéphane Bancel said that "COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone."
The company describes itself as "a leader in the creation of the field of mRNA medicine."
Read On The Fox News App
Rep. Marjorie Taylor Greene Airs Frustrations, Warns That She Represents A 'Not Happy' Republican Base
Greene has previously spoken out against COVID-19 vaccines, saying their FDA approval should be nixed.
"COVID-19 vaccines should have never received approval and they've known the entire time how bad the side effects are and deaths caused by them. It's time to do the right thing. Stop the COVID-19 vaccines," she declared in part of a tweet in March.
Trump Ally Marjorie Taylor Greene Says She Won't Run For Senate While Blasting Dems And Fellow Republicans
The congresswoman is currently serving her third term in the House of Representatives.Original article source: Marjorie Taylor Greene slams FDA green lighting of mNEXSPIKE COVID-19 vaccine: 'Not MAHA at all!!!'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
18 minutes ago
- UPI
Rubio imposes visa bans over Cuba's medical missions program
Secretary of State Marco Rubio on Tuesday announced they were imposing visa bans on government officials linked to Cuba's medical missions program. File Photo by Ken Cedeno/UPI | License Photo June 4 (UPI) -- The U.S. State Department has imposed visa restrictions on an unspecified number of Central American government officials accused of being involved in Cuba's medical mission program. Secretary of State Marco Rubio announced the punitive measure in a statement Tuesday, describing those targeted with the visa restrictions as "officials responsible for Cuban medical mission programs that include elements of forced labor and the exploitation of Cuban workers." "These steps promote accountability for those who support and perpetuate these exploitative practices," Rubio said. "The Cuban labor export program abuses the participants, enriches the corrupt Cuban regime and deprives everyday Cubans of essential medical care that they desperately need in their homeland." According to the State Department's 2024 Trafficking in Persons Report for Cuba, medical professionals comprise 75% of Cuba's exported workforce, generating $4.9 billion of its total $7 billion in service exports in 2022. The United States, citing doctors who have escaped from the program, accuses Cuba of human trafficking and worker exploitation, stating that those deployed to some 50 countries receive little or no pay, have their passports and medical credentials confiscated and have their rights restricted abroad, while also facing repercussions if they leave the program. During the COVID-19 pandemic, Human Rights Watch said the Cuban government imposes "draconian rules" on doctors deployed abroad. The move comes after Rubio, in late February, announced that the State Department was expanding its visa restrictions policy targeting forced labor to enable the blacklisting of those linked to Cuba's labor export programs. Though Cuba has yet to respond to Tuesday's move, it lashed out at the Trump administration following February's announcement, with Havana's foreign minister, Bruno Rodriguez, said the visa restrictions were "based on falsehoods and coercion." Rep. Maria Elvira Salazar, R-Fla., said on X Tuesday that she supports Rubio's visa ban on those who benefit from Cuba's international medical program. "No nation should enrich a dictatorship by exploiting its own people," she said. "It's time to end these slave missions and stand with the Cuban people."
Yahoo
43 minutes ago
- Yahoo
FDA commissioner: Measles killing about one in 1,000 victims
(NewsNation) — Health officials in the U.S. are telling all travelers that regardless of where you're flying to, it's important to make sure you're vaccinated against measles. The Centers for Disease Control and Prevention updated its guidance last week. The health agency previously advised travelers of the importance of vaccination for travelers going to countries that have had an outbreak of the disease. Lead, arsenic found in popular rice brands: Study FDA Commissioner Dr. Marty Makary told NewsNation that measles has a mortality rate of about one in 1,000 people, and usually found in people with co-morbid conditions. But he added that vaccination is effective, and that those who've had the disease before needn't worry. 'It's basically natural immunity once you've recovered from measles,' Makary said. The travel notice advises two vaccination doses for all Americans ages 1 and older. An early dose is advised for traveling infants ages 6 months to 11 months. The U.S. has seen more than 1,000 measles cases so far this year. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
43 minutes ago
- Yahoo
FDA commissioner Marty Makary to review safety of abortion drug mifepristone
June 4 (UPI) -- Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side effects. In a letter to Sen. Josh Hawley, R-Mo., Makary revealed the FDA's plan on Monday to review the abortion pill after Hawley alerted the commissioner to the study. "As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists at the agency who review this data," Makary wrote. "As with all drugs, FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of early pregnancy," Makary added. Hawley referred the FDA commissioner to the recent study, from the Ethics and Public Policy Center, which found 11% of women experienced sepsis, infection or hemorrhaging within 45 days of taking the pill. While Hawley said that information is listed as a side effect for mifepristone, the numbers are 22 times greater than the label warns. The study was based on insurance claims for 865,727 mifepristone abortions between 2017 and 2023. "I'm calling on the FDA to reinstate safety regulations on the chemical abortion drug immediately. New data out today show a massive number of severe medical side effects," Hawley said in April. "The time to act is now." Makary told senators during his confirmation hearing in March that he would oversee a review of mifepristone, but did not order it until Hawley alerted him to the EPPC study. The FDA commissioner did express concerns earlier this year about the Biden administration's policy, which allowed women to access abortion drugs without making in-person appointments. Last year, the U.S. Supreme Court rejected a challenge to the FDA's approval of mifepristone, saying the pro-life doctors who brought the case lacked standing. The court said the Alliance for Hippocratic Medicine failed to prove they suffered any harm from the FDA's policies. President Donald Trump, who supported the Supreme Court's decision, was also urged by Hawley to order a mifepristone review over the EPPC's findings.
